Novartis Targets Teva Over Myfortic Patents

By Erin Marie Daly · April 20, 2011, 4:57 PM EDT

Novartis AG accused Israeli generics maker Teva Pharmaceutical Industries Ltd. in Delaware on Wednesday of infringing a group of its patents related to immunosuppressive agent Myfortic....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Novartis AG et al v. Teva Pharmaceuticals USA Inc.

Case Number

1:11-cv-00353

Court

Delaware

Nature of Suit

Patent

Date Filed

April 20, 2011